BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16527615)

  • 21. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGH gene involvement in two cases of acute lymphoblastic leukemia with t(14;14)(q11;q32) identified by sequential R-banding and fluorescence in situ hybridization.
    Liu S; Bo L; Liu X; Li C; Qin S; Wang J
    Cancer Genet Cytogenet; 2004 Jul; 152(2):141-5. PubMed ID: 15262434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double CEBPE-IGH rearrangement due to chromosome duplication and cryptic insertion in an adult with B-cell acute lymphoblastic leukemia.
    Pierini V; Nofrini V; La Starza R; Barba G; Vitale A; Di Raimondo F; Matteucci C; Crescenzi B; Elia L; Gorello P; Storlazzi CT; Mecucci C
    Cancer Genet; 2011 Oct; 204(10):563-8. PubMed ID: 22137487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular-cytogenetic characterization of non-Hodgkin's lymphoma with double and cryptic translocations of the immunoglobulin heavy chain gene.
    Kanda-Akano Y; Nomura K; Fujita Y; Horiike S; Nishida K; Nagai M; Miura I; Nakamura S; Seto M; Iida S; Ueda R; Taniwaki M
    Leuk Lymphoma; 2004 Aug; 45(8):1559-67. PubMed ID: 15370207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin.
    Nguyen-Khac F; Davi F; Receveur A; Maloum K; Morel V; Le Garff-Tavernier M; Ong J; Berger R; Leblond V; Merle-Béral H
    Cancer Genet Cytogenet; 2005 May; 159(1):74-8. PubMed ID: 15860362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.
    Muñoz-Mármol AM; Sanz C; Tapia G; Marginet R; Ariza A; Mate JL
    Histopathology; 2013 Sep; 63(3):418-24. PubMed ID: 23795946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
    Einerson RR; Law ME; Blair HE; Kurtin PJ; McClure RF; Ketterling RP; Flynn HC; Dogan A; Remstein ED
    Leukemia; 2006 Oct; 20(10):1790-9. PubMed ID: 16888615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing.
    May PC; Foot N; Dunn R; Geoghegan H; Neat MJ
    Cancer Genet Cytogenet; 2010 Apr; 198(1):71-5. PubMed ID: 20303018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characteristics of terminal deoxynucleotidyl transferase negative precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.
    Yoon J; Yun JW; Jung CW; Ju HY; Koo HH; Kim SH; Kim HJ
    Genes Chromosomes Cancer; 2020 Apr; 59(4):255-260. PubMed ID: 31705772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
    Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation.
    Saglio G; Grazia Borrello M; Guerrasio A; Sozzi G; Serra A; di Celle PF; Foa R; Ferrarini M; Roncella S; Borgna Pignatti C
    Genes Chromosomes Cancer; 1993 Sep; 8(1):1-7. PubMed ID: 7691153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal translocations in leukaemia.
    Gauwerky CE; Croce CM
    Semin Cancer Biol; 1993 Dec; 4(6):333-40. PubMed ID: 8142618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
    Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
    Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America.
    Remstein ED; Dogan A; Einerson RR; Paternoster SF; Fink SR; Law M; Dewald GW; Kurtin PJ
    Am J Surg Pathol; 2006 Dec; 30(12):1546-53. PubMed ID: 17122510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
    Merchant S; Schlette E; Sanger W; Lai R; Medeiros LJ
    Arch Pathol Lab Med; 2003 Mar; 127(3):305-9. PubMed ID: 12653573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
    Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
    J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of infantile acute lymphoblastic leukemia presenting with rearrangement of MLL at 11q23 and apparent insertion or translocation at 10p12.
    Tirado CA; Lager J; Rosoff PM; Golembiski-Ruiz V; Gong JZ; Goodman BK
    Cancer Genet Cytogenet; 2004 Oct; 154(1):57-9. PubMed ID: 15381373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.